Literature DB >> 2387093

Anti-cardiolipin antibodies and HIV infection.

C Maclean1, P J Flegg, D C Kilpatrick.   

Abstract

Anti-cardiolipin antibodies of IgG class were found in 48% of intravenous drug users, 38% of homosexuals and 14% of heterosexuals (with no other risk factor) infected with HIV. Anti-cardiolipin antibodies were not increased in HIV-negative heterosexual partners of HIV-infected patients, but mildly elevated levels were detected in HIV-negative drug users, relative to healthy controls unselected for HIV status. Among HIV infected drug users, anti-cardiolipin antibodies were not associated with thrombocytopenia, Pneumocystis carinii pneumonia, disease progression or clinical stage. Anti-cardiolipin antibodies appear to be another non-specific marker of HIV infection which may be particularly common in male intravenous drug users infected with the virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387093      PMCID: PMC1535048          DOI: 10.1111/j.1365-2249.1990.tb03328.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Anti-cardiolipin antibodies in viral infection.

Authors:  C B Colaço; I J Mackie; W Irving; S J Machin
Journal:  Lancet       Date:  1989-03-18       Impact factor: 79.321

2.  Lupus anticoagulant and AIDS.

Authors:  J E Gold; A Haubenstock; R Zalusky
Journal:  N Engl J Med       Date:  1986-05-08       Impact factor: 91.245

3.  Hypergammaglobulinemia and the anticardiolipin antibody test.

Authors:  T P Hughes; P Jones; M C Rozenberg
Journal:  Arthritis Rheum       Date:  1989-06

4.  Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.

Authors:  A J Cohen; T M Philips; C M Kessler
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

5.  Autoimmunity to cardiolipin in infectious mononucleosis.

Authors:  R Misra; P J Venables; R P Watkins; R N Maini
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

6.  Reactivity of anti-histone antibodies induced by procainamide and hydralazine.

Authors:  J P Portanova; R L Rubin; F G Joslin; V D Agnello; E M Tan
Journal:  Clin Immunol Immunopathol       Date:  1982-10

7.  False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion.

Authors:  S Cowchock; J Fort; S Munoz; R Norberg; W Maddrey
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.

Authors:  S Loizou; J D McCrea; A C Rudge; R Reynolds; C C Boyle; E N Harris
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

9.  Anticardiolipin antibodies in homosexual men: prevalence and lack of association with human immunodeficiency virus (HIV) infection.

Authors:  B P Mulhall; G Naselli; S Whittingham
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

10.  Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.

Authors:  J R Batchelor; K I Welsh; R M Tinoco; C T Dollery; G R Hughes; R Bernstein; P Ryan; P F Naish; G M Aber; R F Bing; G I Russell
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

View more
  10 in total

1.  Hyperhomocysteinemia in HIV-Infected Individuals: Correlation of a Frequent Prothrombotic Factor with CD4+ Cell Count.

Authors:  Alireza Abdollahi; Tahereh Sanaei Shoar
Journal:  Oman Med J       Date:  2012-05

Review 2.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

3.  Risk of Venous Thromboembolism in Patients Infected with HIV: A Cohort Study.

Authors:  Ashish Anil Sule; Nihar Pandit; Pankaj Handa; Veerandra Chadachan; Endean Tan; Faith Nadine Choo Yun Sum; Er Hui Ling Joyce; Tay Jam Chin
Journal:  Int J Angiol       Date:  2013-06

Review 4.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

6.  Anticardiolipin antibodies in HIV infection: association with cerebral perfusion defects as detected by 99mTc-HMPAO SPECT.

Authors:  A Rubbert; E Bock; J Schwab; J Marienhagen; H Nüsslein; F Wolf; J R Kalden
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Effect of acute cytomegalovirus infection on drug-induced SLE.

Authors:  A Schattner; Z Sthoeger; D Geltner
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

8.  Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.

Authors:  A Amara; C Chaugier; J M Ragnaud; M Geffard
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

9.  Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.

Authors:  A M Chancellor; R E Cull; D C Kilpatrick; C P Warlow
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

10.  Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era.

Authors:  Laura Iordache; Djaouida Bengoufa; Olivier Taulera; Agathe Rami; Caroline Lascoux-Combe; Nesrine Day; Maguy Parrinello; Pierre-Olivier Sellier; Jean-Michel Molina; Alfred Mahr
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.